Literature DB >> 2139324

Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).

R Fears1, I Dodd, H Ferres, J H Robinson.   

Abstract

The activation of plasminogen by two novel hybrid enzymes, constructed from the A-chain of plasmin and the B-chains of tissue-type plasminogen activator (t-PA) or urokinase, was compared with the activation by the parent enzymes. Basal kinetic constants for 'Lys-plasminogen' (human plasminogen with N-terminal lysine) and 'Glu-plasminogen' (human plasminogen with N-terminal glutamic acid) activation were similar to those of the parent activators. The Km for plasminogen turnover for both hybrid enzymes was considerably decreased in the presence of both soluble fibrin and a mimic, a CNBr digest of fibrinogen. These enhancements and the related apparent negative co-operativity are similar to the behaviour of t-PA itself. The results are discussed with regard to the molecular features involved in the mechanism of fibrin stimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139324      PMCID: PMC1131195          DOI: 10.1042/bj2660693

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.

Authors:  L C Petersen; J Brender; E Suenson
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

2.  Kinetic studies on the effect of heparin and fibrin on plasminogen activators.

Authors:  R Fears
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

3.  Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.

Authors:  I Dodd; R Fears; J H Robinson
Journal:  Thromb Haemost       Date:  1986-02-28       Impact factor: 5.249

4.  Slow clearance of acylated, hybrid thrombolytic enzymes.

Authors:  J H Robinson; I Dodd; A Esmail; H Ferres; B Nunn
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

5.  The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.

Authors:  R Cassels; R Fears; R A Smith
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

6.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

7.  Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.

Authors:  C Zamarron; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

8.  Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.

Authors:  R Fears; M J Hibbs; R A Smith
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

9.  Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.

Authors:  M J Browne; I Dodd; J E Carey; C G Chapman; J H Robinson
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

10.  Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.

Authors:  P P Lee; R C Wohl; I G Boreisha; K C Robbins
Journal:  Biochemistry       Date:  1988-09-20       Impact factor: 3.162

View more
  1 in total

1.  A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.

Authors:  M S Runge; T Quertermous; P J Zavodny; T W Love; C Bode; M Freitag; S Y Shaw; P L Huang; C C Chou; D Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.